WCG MedAvante-ProPhase
Pharmaceutical Manufacturing • 
Trenton, New Jersey, United States • 101-200 Employees
Company overview
| Headquarters | 100 American Metro Boulevard, #106, Hamilton, New Jersey 08619, US |
| Phone number | +10008000503467 |
| Websites | |
| NAICS | 3254 |
| SIC | 737 |
| Keywords | Clinical Trials, Risk Reduction, Signal Detection, Clinical Over-Read (Central Review), Rater Training |
| Founded | 2002 |
| Employees | 101-200 |
| Socials |
Key Contacts at WCG MedAvante-ProPhase
Evan Fosu
Associate Director, Information & Network Security, It Infrastructure
Paul Gilbert
Ceo, Co-Founder
Patricia Sukovich
Senior Director Of Operations
WCG MedAvante-ProPhase Email Formats
WCG MedAvante-ProPhase uses 5 email formats. The most common is {first name}{last name} (e.g., johndoe@medavante.com), used 52.8% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@medavante.com | 52.8% |
{first initial}{last name} | jdoe@medavante.com | 30.6% |
{first initial} | j@medavante.com | 5.6% |
{first name}.{last name} | john.doe@medavante.com | 5.6% |
About WCG MedAvante-ProPhase
WCG MedAvante-ProPhase is the leading global provider of technology-enabled signal detection solutions in clinical trials of treatments for central nervous system (CNS) disorders with more than two decades of experience improving clinician-reported diagnostic and outcome measurements. MedAvante-ProPhase standardizes rating scale administration and scoring with the Virgil® Investigative Study Platform, a powerful approach to signal detection that puts the advantages of our experience in the hands of site raters as a tablet computer with unique context-sensitive electronic rating scale forms and study-specific clinical guidance, designed by clinicians for clinicians. We prepare and qualify clinical raters with effective, measurable rater training, and we assure ongoing data quality with Independent Review, over-read of assessment outcomes by expert central clinicians. Maximal protection against the risk of inconclusive results is delivered by MedAvante-ProPhase Independent Ratings, which in addition to standardizing scale administration and scoring avoids critical sources of perception bias that may block signal detection. Continuously trained and standardized remote Expert Clinicians are blind to protocol details and subject history, immune to the confounding impact of repeated contact with patients and free of pressure to enroll subjects. Independent Ratings have been used in more than 57 major trials completed to date. Supported by operations teams in the US, Germany, Russia and Japan, MedAvante-ProPhase delivers services for clinical trials in more than 40 countries worldwide. For more information, please visit www.medavante.com.
WCG MedAvante-ProPhase revenue & valuation
| Annual revenue | $9,924,380 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $31,800,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
WCG MedAvante-ProPhase has 40 employees across 8 departments.
Departments
Number of employees
Funding Data
WCG MedAvante-ProPhase has never raised funding before.
WCG MedAvante-ProPhase Tech Stack
Discover the technologies and tools that power WCG MedAvante-ProPhase's digital infrastructure, from frameworks to analytics platforms.
Security
Security
Video players
CDN
WordPress plugins
Miscellaneous
Security
Programming languages
Blogs
Analytics
SEO
Tag managers
United Kingdom
Spain
France
Australia
Frequently asked questions
4.8
40,000 users
